Phase 3 data show lebrikizumab improves skin clearance and itch in children with moderate to severe atopic dermatitis, ...
Expert Rev Anti Infect Ther. 2011;9(3):283-284. Pediatric patients are not simply 'little adults'. This mantra can be echoed throughout the entire discipline of pediatric medicine, where differences ...
Pediatric patients with moderate to severe hidradenitits suppurativa may now receive secukinumab following new FDA approval ...
Please provide your email address to receive an email when new articles are posted on . Researchers confirmed the dosing of a formulation including dolutegravir, abacavir and lamivudine in children ...
Duke Medicine is part of a groundbreaking initiative to reduce the risk and dangers faced everyday by millions of children who are prescribed medications that lack definitive data about pediatric ...
Riding in the back of an ambulance managing a very sick child is far from the ideal time for a paramedic to do math. But often paramedics must do a few calculations in their heads to determine the ...
Larimar Therapeutics has initiated dosing for adolescents aged 12-17 in its pediatric pharmacokinetic (PK) run-in study for nomlabofusp, a potential treatment for Friedreich’s ataxia. Adolescents who ...
Vendor-supplied dosing eRules are not optimal for pediatric patients, according to a study in the Journal of the American Medical Information Association. Researchers studied seven months of ...
Augmentin (amoxicillin/clavulanate potassium) is a brand-name drug prescribed for specific bacterial infections in adults and children. Augmentin comes as an oral ...
KALAMAZOO, Mich.—Breaking through long-standing norms, a team of interdisciplinary researchers from Western Michigan University and the WMU Homer Stryker M.D. School of Medicine (WMed) received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results